3-(4-(2-(2-chloro-4-fluorophenyl)-1-(1H-indazol-5-yl)but-1-en-1-yl)phenyl)acrylic acid,
ARN-810,
GDC-0810,
Brilanestrant,
GDC-0810,
1365888-06-7,
ARN-810,
UNII-9MM2R1A06R,
(E)-3-(4-((E)-2-(2-Chloro-4-fluorophenyl)-1-(1H-indazol-5-yl)but-1-en-1-yl)phenyl)acrylic acid,
9MM2R1A06R,
CHEMBL3581693,
GDC 0810,
GDC-0810(ARN-810),
Brilanestrant [USAN],
Brilanestrant; ARN-810,
SCHEMBL766995,
ARN810,
ARN 810,
Gdc-0810 (arn-810),
GDC0810,
BURHGPHDEVGCEZ-KJGLQBJMSA-N,
brilanestrant-gdc-0810-arn-810,
BCP24812,
EX-A2378,
BDBM50090462,
MFCD28902190,
ZINC114545220,
CS-4588,
DB12253,
RG-6046,
GDC-0810; Brilanestrant; ARN-810,
AK174908,
Brilanestrant (GDC-0810, ARN-810),
HY-12864,
A15958,
1446090-77-2,